Globális agyi ischaemia hatása két különböző patkánytörzs kérgi aktivitására és egy új lehetséges neuroprotektív stratégia tesztelése by HASH(0x7fe990301548)
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY OF PH.D. THESIS 
THE EFFECTS OF GLOBAL BRAIN ISCHEMIA ON 
THE CORTICAL ACTIVITY OF TWO DIFFERENT RAT 
STRAINS AND INVESTIGATION OF A NEW POSSIBLE 
NEUROPROTECTIVE STRATEGY 
 
János Fuzik 
 
 
Supervisor: 
Tamás Farkas Ph.D. 
Associate Professor 
 
 
UNIVERSITY OF SZEGED 
FACULTY OF SCIENCE AND INFORMATICS 
DEPARTMENT OF PHYSIOLOGY, ANATOMY AND 
NEUROSCIENCE 
 
 
2013 
SZEGED 
List of abbreviations 
 
- 4VO:4-vessel occlusion 
- BSR: burst suppression ratio 
- CA1: cornum ammon region 1 
- CBF: cerebral blood flow 
- CCA: common carotid artery 
- DHEA: dehydroepiandrosterone 
- EAAT: excitatory aminoacid transporter 
- ECoG: electrocorticogram 
- fEPSP: field-excitatory postsynaptic potential 
- FJ-C: Fluoro Jade C 
- FB: first burst 
- Glu: glutamate 
- GOT: glutamate-oxaloacetate transaminase 
- I/O: input/output 
- ISF: interstitial fluid 
- LTP: long-term potentiation 
- NF-κB: („nuclear factor kappa-light-chain-enhancer of activated B cells”) 
- NMDA: N-methyl-D-aspartate 
- OxAc: oxaloacetate 
- SD: Sprague-Dawley 
- TBS: theta burst stimulation 
- TNFα: tumor necrosis factor-α 
 
 
 
 
Introduction 
 
The annual number of deaths worldwide is approximately 60 million, 60% of which are 
caused by noninfectious diseases such as cancer or neurodegeneration. Half of these cases 
involve malfunctions of the cardiovascular system. Disturbance of the blood supply of the 
brain is one of the most frequent cerebrovascular diseases. Only a particular area of the brain 
is involved during hemorrhagic and ischemic stroke, but the whole body, including all 
regions of the brain, suffers from the lack of oxygen and substrates when cardiac arrest 
occurs. Accordingly, different experimental models of ischemia are required which 
correspond to the various clinical pathophysiological situations. The 4-vessel-occlusion 
(4VO) model is suitable for inducing global cerebral ischemia ischemia in experimental 
animals. Many independent research groups have reported significant discrepancies between 
the data recorded in human pathophysiological states and the data obtained from animal 
experiments. It should be borne in mind that there is a considerable diversity in cerebral 
vascular architecture in the different species, and there are also interstrain and even 
intrastrain anatomical differences in the vasculature of rats. There are striking differences in 
the physiological functions of Sprague-Dawley (SD) and Wistar rat strains at many levels, 
e.g. behavior, learning and memory, enzymatic activity, gene expression and focal ischemic 
injury. Both Wistar and SD rats are widely used in experiments involving global ischemia, 
such as 4VO. No previous data demonstrate whether any difference in cerebral cortical 
activity and the consequent histological changes can be observed following global cerebral 
ischemia in Wistar and SD rats supplied by the same vendor (Charles-River Laboratories). It 
should also be emphasized that such differences can greatly influence the results of 
experiments and even the clinical application of neuroprotective strategies. 
We discovered striking differences between SD and Wistar rats when we applied 4VO 
surgical intervention. It has already been published that a highly increased cytosolic 
concentration of Ca2+ ions plays a prominent role in the functional and cellular loss after 
ischemia. A second elevation of Ca2+ occurs after the ischemic insult, which is responsible 
for the apoptotic effects following hypoperfusion. Free radicals are formed as a result of the 
reduced blood flow. These influence the excitatory transmitter release of neurons which can 
enhance the processes of free radical formation. Thus, if there are huge discrepancies in the 
cerebral blood flow (CBF) of SD and Wistar rats during 4VO, this can explain the 
differences seen between the two rat strains. 
In a second series of experiments we investigated a possible new neuroprotective strategy 
applied as combined treatment with two endogenous compounds. The treatment was 
designed to moderate both the early and the late ischemic events and to protect the 
hippocampal pyramids from the loss of synaptic function and from cell death. The excess 
glutamate (Glu) which appears in the interstitial fluid (ISF) immediately after the start of 
ischemic period, increases the intracellular Ca2+ concentration through the activation of N-
methyl-D-aspartate (NMDA) receptors. The high Ca2+ concentration leads to the release of 
Ca2+ from the intracellular storages. Although glial cells have their excitatory amino acid 
transporters (EAAT) activated, these work in a reversed way when the Glu level is extremely 
high. The membrane potential of the endothelial cells with EAAT transporters in their 
membrane is much more stable during ischemic conditions and may therefore reduce the 
excess Glu when ischemia occurs. It is reasonable to say that the extremely high Glu level of 
the ISF could be a valuable point of attack a neuroprotective strategy. The concentration 
gradient between the ISF and the blood plasma can be increased by decreasing the Glu 
concentration of the blood plasma by activating the glutamate-oxaloacetate transaminase 
(GOT) enzyme. Through its transaminase activity GOT converts glutamate to 2-α-
ketoglutarate and oxaloacetate (OxAc) to aspartate. The Glu efflux from the brain to the 
blood is enhanced when the Glu level in the blood plasma decreases. This is the 
phenomenon of Glu scavenging. Early consequences of the ischemic insult are handled by 
the Glu-scavenger OxAc, but late ischemic events such as inflammatory events take place a 
few hours or days after the insult. During these processes the affected area is characterized 
by elevated interleukin-1 and interleukin-6 concentration. The expression of tumor necrosis 
factor α (TNFα)-activated NF-κB (nuclear factor kappa-light-chain-enhancer of activated B 
cells), which regulates the major genes responsible for inflammation, cell proliferation and 
apoptosis, is also increased. Dehydroepiandrosterone (DHEA), an endogenous neurosteroid, 
has been proved to moderate inflammation due to its numerous neuroprotective effects. 
DHEA is capable of decreasing the activation of NF-κB and the level of interleukins. Under 
ischemic conditions, when the extremely high intracellular Ca2+ concentration is close to its 
cytotoxic level, DHEA treatment can prevent Ca2+ ions from flowing into the mitochondrial 
matrix. Furthermore, DHEA activates Akt kinase, a serine-threonine kinase, which is known 
to contribute to inhibition of the apoptotic cascade in its active form.  
With our combined treatment, we are able to moderate both the early ischemic and the late 
ischemic events following an ischemic period which can result in significant functional and 
cell loss. Thus, the application of combined treatment to diminish excitotoxic and 
inflammatory processes is expected to lead to much more effective neuroprotection. 
  
Aims 
 
1. We discovered marked interstrain differences between rats from the Wistar and from the 
SD strains when we performed 4VO global ischemia surgery. It is well known that there are 
striking differences in the physiological functions of the two rat strains at many levels, e. g. 
behaviour, learning and memory, enzymatic activity, gene expression. We hypothesize that 
there is a huge difference in the vascular anatomy of the two strains. Therefore we expect the 
10 min of global cerebral ischemia to result in other types of cortical activity and in different 
magnitude of cell loss. In order to clarify the origin of these discrepancies we set to 
carry out in vivo electrophysiological (ECoG) and histological (Fluoro Jade C, Evans 
Blue and Cresyl violet) experiments.   
 
2. We are planning to examinate the neuroprotective effects of OxAc on 4VO Wistar rats. 
Transient global cerebral ischemia with a duration of 10 min is going to be performed and 
we investigate the neuroprotection of Glu scavenging in comparison to the reduced synaptic 
plasticity after 4VO. OxAc treatment is capable of moderating the impairment of synaptic 
plasticity after ischemia according to our previous results. In order to decrease the dose of 
OxAc, we administer DHEA as another endogenous compound. Thus we would apply a 
combined treatment in order to decrease the damage caused by both the early and the late 
ischemic events after 4VO. We investigated the neuroprotective effects of OxAc in in 
vivo electrophysiological experiments (ECoG recordings), and the effectiveness of the 
combined treatment in in vitro electrophysiological experiments (LTP measurements). 
 
 
 
 
 
Materials and methods 
 
Animals and housing conditions  
Male Charles River rats of the Wistar strain (N=80) and of the Sprague-Dawley strain 
(N=20) were used. Animals weighing 200–300 g were applied. They were maintained on 
food and water, ad libitum. Every effort was made to minimize animal suffering and the 
number of sacrificed animals. The protocols for animal care approved by both the Hungarian 
Health Committee and the European Communities Council Directive of 24 November 1986 
(86/609/EEC) were followed. 
 
The 4VO ischemic modell 
Preparation of the transient global cerebral ischemia model (4VO) 
The 4VO procedure was performed under sodium pentobarbital anesthesia (60 mg/kg, i.p.). 
Both vertebral arteries were electrocauterized through the alar foramens located on the 
lateral surface of the atlas. 24 h later under sodium pentobarbital anesthesia (60 mg/kg, i.p.), 
the bilateral common carotid arteries (CCAs) were clamped with non-traumatic aneurysm 
clips for 10 min. Body temperature was monitored and maintained at 37 °C by an automatic 
heat controller desk. 
 
In vitro electrophysiology 
The electrophysiological recordings were carried out 8 days after the 4VO. The rats were 
decapitated, and vibratome-cut 350-μm coronal slices were prepared from the middle part of 
their dorsal hippocampi. The stimulating electrode, a concentric bipolar platinum-iridium 
electrode, was placed in the stratum radiatum near the border between the CA1 and CA2 
subfields as to allow orthodromic stimulation of the Schaffer collateral/commissural 
pathway. Field excitatory postsynaptic potentials (fEPSPs) were recorded from the stratum 
radiatum and stratum pyramidale. LTP of the Schaffer collateral-CA1 synaptic response was 
induced by theta-burst stimulation (TBS) at 100% intensity of the test stimulus. After the 
LTP induction, the increased fEPSPs were recorded during at least a 60-min follow-up 
period. When the amplitudes were generally stable, their mean value was determined as the 
10-min-long baseline. Input-output (I/O) curves were created to measure the basal Glu-ergic 
synaptic transmission.  
 
In vivo electrophysiology 
Electrocorticogram (ECoG) recordings were carried out on Wistar rats under sodium 
pentobarbital anesthesia (60 mg/kg i.p.). The skull was opened by drilling at the stereotaxic 
coordinates of the primary motor and somatosensory cortices. Four epidurally positioned 
silver-ball electrodes with an eight-channel electroencephalograph were applied to record 
electrocortical activity against a common central reference placed on the median line 5 mm 
anterior to the bregma. After the recording of a 15-min baseline, 10 min of 4VO was 
performed and the electrocortical activity was monitored for a further 50 min after the global 
cerebral ischemia. The sampling frequency was 200 Hz. We analyzed the burst suppression 
ratio (BSR), the number of spikes appearing 10-15 min after the start of reperfusion 
following the 10-min 4VO, the frequency composition of the ECoG after the FB under 
ischemic conditions, and the effects of OxAc on these parameters. 
 
Data analysis 
BSR analysis 
Intermittent cortical activity observed after the ischemic insults, was quantified by 
estimating the BSR defined as the percentage of time spent in suppression. We applied the 
method of Vijn and Sneyd (1998) for burst identification. The resolution of the BSR 
estimation was 10 s. The absolute value of the 5 min baseline period of every channel was 
used to determine BSR repeatedly with a decreasing voltage threshold and with 200 ms as 
the minimum allowed BS duration. A threshold with a BSR value of <5% (20-25 µV on 
average) was used to monitor the changes in BSR after the first burst (FB) following 
transient global cerebral ischemia. 
 
Threshold-crossing event detection 
After global cerebral ischemia, 10-15 min of isoelectric ECoG can be measured. After the 
FB a post-ischemic burst period follows the isoelectric period which is approximately 20 
min long as it is characterized by a higher rate of firing. The number of threshold-crossing 
spikes in every 5 min was determined in the 30-min-long period after the FB and divided by 
the number of spikes counted in the period between 30-35 min after the FB. 
 
Spectral density estimation 
To convert ECoG data from time-domain to frequency-domain and to compute the discrete 
Fourier transform and its squared magnitude, the method of Welch was used to calculate 
periodograms in order to estimate the power of ECoG at different frequencies. Every first 30 
s of every 5-min period of ECoG after the FB was measured. The segment length comprised 
300 data points with 50% overlap.  
 
Statistical analysis 
 
For LTP analysis, maximum fEPSP amplitudes were expressed as percentages of that of the 
baseline. The data were tested with the Shapiro–Wilk normality test and the Levene test. 
Since the results of the normality tests were significant and the requirement for the 
homogeneity of variances was not satisfied, further analysis was carried out with the non-
parametric Kruskal–Wallis test and the pairwise comparisons of the groups with Mann-
Whitney U-test. Analysis of the input–output curves was carried out with pairwise 
comparisons of the groups, related to certain input stimulus were also achieved with the 
Kruskal–Wallis ANOVA. The effects of the different rats were used as random effects and 
the different treatments were used as fixed effects in the mixed effect linear model. The 
normal distribution of the BSR data could not be presumed using the Shapiro–Wilk 
normality test and the Levene test did not demonstrate an equality of variances. Therefore 
Mann-Whitney U-test as a non-parametric test on two independent samples was chosen for 
statistical analysis of the BSR data. The normal distribution of the threshold-crossing event 
count data could be observed according to the Shapiro–Wilk normality test. The one-sample 
T-test was used to determine the significance of difference between the two groups. In every 
case levels of significance were * = p≤0,05; ** = p≤0,01; *** = p≤0,001.  
 
Histology 
 
The animals were transcardially perfused with 4 % paraformaldehyde. In the 4VO 
experiments 20 μm thick coronal sections were made in the stereotaxic coordinates of -2,3 
mm to -4,3 mm from bregma. 
 
Fluro Jade-C staining 
The brains were removed, and postfixed overnight in paraformaldehyde at 4°C. To reveal 
neuronal degeneration, staining with Fluoro Jade C (FJ-C) was applied, which has a high 
affinity for the entire degenerating neuron, including cell body, dendrites, axon and axon 
terminals. The slides were cover-slipped with Fluoromount and subsequently protected from 
direct light. 
 
Cresyl violet 
Morphological properties of CA1 pyramids were assessed by means of conventional cresyl 
violet nuclear staining. 
 
Evans Blue staining 
For Evans blue staining, permanent 4VO was carried out. Immediately after cauterization of 
the vertebral arteries both CCAs were exposed and two ligatures were placed upon each. 
Between the two ligatures, the arteries were severed in order to ensure interruption of the 
carotid flow. For the detection of the cerebral blood flow occurring during 4VO, the animals 
were perfused transcardially with 50 ml of 3% buffered Evans blue dye. The brains were 
removed, and postfixed overnight in 4% paraformaldehyde at 4°C. Coronal sections (20 µm) 
were obtained at the level corresponding to ECoG recording electrodes and were mounted on 
slides coated with 2% gelatin. The slides were cover-slipped with Fluoromount and 
subsequently protected from direct light. 
 
Drug administration 
 
Oxaloacetate 
 
Oxaloacetate (OxAc) was dissolved in TBS buffer and adjusted to pH 7.3 with NaOH (10 
N). The total volume administered was 1 ml. OxAc was injected i.v. during 15 min 
immediately after the end of the 10-min 4VO. Low-dose OxAc group received a dose of 4 
mg/100 g bw while the  high-dose OxAc group received 20 mg/ 100 g bw OxAc.  
 
Dehydroepiandrosterone (DHEA) 
 
DHEA was dissolved in 97% abs. EtOH and administered i.p. in corn oil in a concentration 
of 10 mg/ml in a total volume of 0.5 ml and it was administered 24 h after the transient 
global cerebral ischemia, in a dose of 2 mg/100 g body weight. 
 
 
 
 
 
Results 
 
1. The analysis of our ECoG data showed that the cortical activity was not completely 
blocked in the SD rats during the 10-min-long 4VO, and there was no sign of a post-
ischemic burst period either. In the Wistar rats, we recorded isoelectric ECoG, during the 10-
min 4VO and during the first 10-15 min of the reperfusion phase followed by a 30-min post-
ischemic burst period. The BSR analysis indicated that the proportion of isoelectric ECoG 
periods increased at the expense of continuous firing during the post-ischemic burst activity. 
25 min after the FB, BSR% values in th Wistar rats were 40-50%. BSR% for the SD rats 
already decreased to 5-10% during the 10-min 4VO, and further decreased to 0% 
immediately after the start of the reperfusion phase. This means that the cortical firing 
became similar to that seen in the baseline period. The cortical activity was characterized by 
the number of ECoG spikes. The lack of the post-ischemic burst period was also confirmed 
by the changes in the number of ECoG spikes after 4VO in the SD animals. In the Wistar 
rats we measured a more than 300% increase in the number of ECoG spikes in the 15th min 
following the FB. The ratio of the frequency components changed after the 10-min 4VO in 
both strains, but the frequency composition of the ECoG in the SD rats returned to that of the 
baseline in the 30th min after the FB. In the Wistar animals, the spectral density in the 30th 
min after the FB and that of the baseline were strongly different. The Fluoro Jade and cresyl 
violet hippocampal stainings revealed a pronounced difference in the magnitude of cell loss 
after 4VO. The SD rats displayed a much smaller amount of degenerated or dead cells in 
their hippocampal CA1 region after 10 min of 4VO. The neurons in the cortical areas of the 
ECoG recordings exhibited a much more intense Evans blue labeling after the permanent 
4VO followed by the transcardial perfusion with the fluorescent dye in the SD animals than 
in the Wistar rats. The cerebral areas were less perfused in the Wistar rats during permanent 
4VO. The capillaries of the cerebral cortex were still filled with blood after transcardial 
perfusion of the Wistar animals with phosphate buffer. The blood was washed out from the 
cerebral cortex of the SD rats and it demonstrated a strong labeling with Evans blue. Cortical 
neurons demonstrated a strong Evans blue staining, since they had the occasion to take up 
the Evans blue labeled serum albumin getting through the blood-brain-barrier disrupted by 
the ischemic conditions. In order to design a potent neuroprotective strategy, we use, an 
ischemic rat model which involves a sufficient amount of degenerated and dead cells to 
allow investigations of the neuroprotective effects of potential neuroprotectants. Our results 
we suggested that Wistar strain was an ideal animal for the 4VO surgery. 
2. The neuroprotective effects of low- and high-dose OxAc administration, DHEA 
adminisration and combined treatment were examined on coronal hippocampal brain slices 
from the brains of 4VO animals 8 days after the ischemic insult. In the sham-operated 
animals, LTP induction by theta-burst stimulation resulted in a 150% increase of the fEPSP 
amplitudes relative to the baseline. In the 4VO group, the fEPSPs recorded following the 
LTP induction attained a maximum increment of only 128% and it gradually decreased 
during the 60-min follow-up to 109%. I.v. low-dose OxAc did not increase the fEPSP 
amplitudes after the theta-burst stimulation in comparison with the 4VO group. 
Administration of the high-dose OxAc resulted in a significant 133% growth of the induced 
LTP. DHEA treatment proved to cause an increasing tendency compared to the 4VO group, 
which was not significant during the 60-min recording. In contrast, the combined treatment 
was successful in restoring the impaired LTP to approximately 144%, i.e. nearly the value 
for the sham-operated group, and it was stable during the 60-min post-theta recording. There 
was no significant difference between the results of the sham-operated and the combined 
treated group. I/O curves were recorded to investigate the condition of the basal Glu-ergic 
transmission. Curves were established by plotting the fEPSP amplitude against different 
intensities of the test pulse ranging from 10 to 100 μA. The transient global cerebral 
ischemia affected the functioning of the Glu-ergic transmission machinery adversely and 
reduced the maximum measurable fEPSP from 3 mV to 1 mV. High-dose OxAc and DHEA 
separately caused a 150% increase of the fEPSP amplitudes in respect of the 4VO group, to 
approximately 1.5 mV. Combined treatment with high-dose OxAc and DHEA restored the 
impaired basal Glu-ergic transmission to a maximum value of 2.8 mV. Neuroprotective 
effects of OxAc on the early excitotoxic phase were investigated after 10 min of 4VO. The 
results of the BSR analysis of the ECoG data showed the appearance of a 20-min post-
ischemic burst period after the FB. In this burst period, the proportion of isoelectric ECoG 
increased compared to that in the firing periods. BSR% was 40-50% after the 25-min period 
following the FB. Administration of OxAc in the high dose (20 mg/100 g bw) resulted in a 
decrease of BSR%. Furthermore, we determined the spike count in the 30-min period after 
the FB. The number of spikes decreased in the post-ischemic burst phase of the OxAc group. 
Thus, we assumed that OxAc could decrease the Glu concentration of the ISF by expressing 
its Glu scavenger effect. OxAc exhibited neuroprotection in changing the ratio of the ECoG 
frequency components. In the control group, the spectral density was significantly different 
in the baseline and at 30 min after the FB. In the OxAc group, the spectral density curves in 
the identical periods were similar. The ratio of the frequency components returned to that of 
the baseline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions 
 
The use of different rat strains (e.g. Wistar vs. SD) can be a source of considerable 
variability in the results of acute experiments on global ischemia and it is important that the 
laboratory rats used in such experiments should be carefully chosen. We therefore studied 
Wistar and SD rats to determine whether there were interstrain differences in the responses 
to global ischemia elicited by 4VO in terms of the acute spontaneous electrical activity of the 
cerebral cortex and the consequent neurodegeneration. We saw striking differences between 
the two rat strains in the BSR% values, in the number of post-ischemic ECoG spikes, in the 
pattern of the first 20 s after FB, and in the proportion of the frequency components during 
and after 4VO. FJ-C and cresyl violet stainings demonstrated sporadic cell death in the 4VO 
SD and a much higher magnitude of apoptotic cell death in the hippocampus of the 4VO 
Wistar rats. We can conclude that in contrast with the SD strain, the Wistar rat is adequate 
4VO model for testing neuroprotective strategies.  
A combined treatment with endogenous compounds was tested as a promising new 
neuroprotective strategy in the hippocampal CA1 region. DHEA treatment itself resulted in 
only a slight increase in the induced LTP level. OxAc was significantly neuroprotective. 
Combined treatment resulted in strong neuroprotection and there was no significant 
difference between the results of the negative control and the results of the combined treated 
group. Our in vivo experiments revealed that the neuroprotective effects of OxAc can be 
seen after 30 min. It was sufficient to administer OxAc once, immediately after the ischemic 
insult, in order to achieve neuroprotection. DHEA is able to downregulate late ischemic 
events such as inflammatory processes. DHEA additionally has many neuroprotective 
activities which also contribute to decreases in neuronal and functional loss in the affected 
area. Both compounds are endogenous and occur naturally in the body. This combined 
treatment could be tested more safely in human trials than could synthetic exogenous 
molecules. Combined treatment could be a promising new neuroprotective strategy in the 
clinical care of stroke. 
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